Oral Versus Injection Therapy for Patients With RRMS - Neurology Live

An expert in neurology provides insight into the considerations of oral versus injectable therapies in patients with multiple sclerosis, highlighting their impact on quality of life, brain volume, and cognitive health.

Heidi Crayton, MD: We have a lot of data with our newer products and our not-quite-as-new products. In terms of efficacy with patients that started off on an injectable-platform therapy and then swit… [+2131 chars]

full article...